Clinical Neurospectroscopy

16:30         136.      Multi-Modality MR Approach to Assess Metabolism and Perfusion in the Human Brain During Hypoglycemia

Marinette van der Graaf¹, Bastiaan E. de Galan¹, Dennis W.J. Klomp¹, Laura M. Parkes², Cees J.J. Tack¹,

Arend Heerschap¹

¹Radboud University Nijmegen Medical Center, Nijmegen, Netherlands; ²Radboud University Nijmegen, Nijmegen, Netherlands

16:42         137.      Early Proton Magnetic Resonance Spectroscopy in Newborn Infants with Perinatal Cerebral Hypoxic-Ischemic Injury: Metabolite Peak-Area Ratios, Relaxation Times, Concentrations and Concentration Ratios.

Jeanie LY Cheong¹, Ernest B. Cady², Juliet Penrice¹, John S. Wyatt¹, I Jane Cox³, Nicola J. Robertson¹

¹University College London, London, UK; ²University College London Hospitals NHS Trust, London, UK; ³Hammersmith Hospital, Imperial College London, London, UK

16:54         138.      In Vivo Glycine Detection with TE-Averaged ¹H-MRS - not available

Andrew P. Prescot¹, Blaise deB Frederick¹, Yong Ke¹, John Brown², Liqun Wang², Marc J. Kaufman¹,

Perry F. Renshaw¹

¹McLean Hospital, Belmont, Massachusetts, USA; ²GlaxoSmithKline, Greenford, London, UK

17:06         139.      Quantitative Proton MRS of Pelizaeus-Merzbacher Disease: Evidence for Dys- And Hypomyelination - not available

Peter Dechent¹, Knut Brockmann¹, Petra Pouwels², Steffi Dreha-Kulaczewski¹, Gunther Helms¹, Bernd Wilken¹,

Folker Hanefeld¹, Jens Frahm²

¹Medical Faculty, University Göttingen, Göttingen, Germany; ²MPI for Biophysical Chemistry, Göttingen, Germany

17:18         140.      Acute Disseminated Encephalomyelitis: Evaluation with Proton MR Spectroscopic Imaging - not available

Anna Gambini¹, Sayed A. Fatemi¹, Thomas O. Crawford¹, Eric H. Kossoff¹, Alena Horska¹, Peter B. Barker¹

¹Johns Hopkins University, Baltimore, Maryland, USA

17:30         141.      Detection of Axonal Damage in the Spinal Cord in Multiple Sclerosis by Magnetic Resonance Spectroscopy

Andrew M. Blamire¹, Zaheer Cader², Martin Lee², Jackie Palace², Paul M. Matthews²

¹University of Newcastle upon Tyne, Newcastle upon Tyne, Northumberland, UK; ²University of Oxford, Oxford, UK

17:42         142.      Macromolecular and Lipid Contributions in Short Echo Time ¹H MRS at 4 Tesla: 1) Reliability in Normal Controls and 2) Comparative Study Between Amyotrophic Lateral Sclerosis Patients and Controls - not available

Lana G. Kaiser¹, Karl Young¹, Brian J. Soher², Michael W. Weiner¹

¹University of California San Francisco, San Francisco, California, USA; ²University of Miami, Miami, Florida, USA

17:54         143.      Traumatic Brain Injury: 3 Tesla Magnetic Resonance Spectroscopic Imaging and Cognitive Function

William Miles Brooks¹, Cary Savage¹, Robin Aupperle¹, Thomas Malone¹, Allan Schmitt¹, JoAnn Lierman¹,

Anda Popescu¹, Mihai Popescu¹

¹University of Kansas Medical Center, Kansas City, Kansas, USA

18:06         144.      Correlation of Quantitative in Vivo ¹H MRS of Untreated Pediatric Medulloblastoma with Quantitative Histological Features

Xiaodong Liu¹, Ignacio Gonzalez-Gomez¹, Ashok Panigrahy¹, Mark D. Krieger¹, Gordon J. McComb¹,

Marvin D. Nelson¹, Floyd H. Gilles¹, Stefan Bluml^1,2

¹Childrens Hospital Los Angeles, Los Angeles, California, USA; ²Rudi Schulte Research Institute, Santa Barbara, California, USA

18:18         145.      Proton MRSI Biomarkers Predict Survival in Children with CNS Tumors - not available

Loukas G. Astrakas^1,2, David Zurakowski, ^2,3, Karen J. Marcus, ^2,4, Maria K. Zarifi^1,5, Umberto DeGirolami, ^2,6,

Peter McL Black, ^2,4, Nancy J. Tarbell, ^2,7, A. Aria Tzika^1,2

¹Massachusetts General Hospital, Boston, Massachusetts, USA; ²Harvard Medical School, Boston, Massachusetts, USA; ³The Children’s Hospital, Boston, Massachusetts, USA; ⁴The Children’s Hospital, Dana Farber Cancer Institute, Brigham & Women's Hospital, Boston, Massachusetts, USA; ⁵Agia Sophia Children's Hospital, Athens, Attiki, Greece; ⁶The Children's Hospital, Brigham & Women's Hospital, Boston, Massachusetts, USA; ⁷Massachusetts General Hospital, Dana Farber Cancer Institute, Boston, Massachusetts, USA